According to the Orange County Register, 46-year-old Thomas McGee received Botox injections in October 2008 to help ease his back pain. Four days after receiving the injections he contracted Guillain-Barre Syndrome, an autoimmune disease.
McGee claims that Allergan was aware the drug could cause Guillain-Barre Syndrome because of internal documents that showed the disease as a top safety concern. He added that Botox should have issued a warning on the drug that said it could lead to the crippling disease.
The dangerous drug lawsuit also states the McGee’s doctor who administered the injections was paid a total of $360,000 over a ten year period to promote the “off label” uses of Botox.
A panel jury awarded McGee $12 million in compensatory damages and $200 million in punitive damages.
If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you and represent your case.